
THE APEX TIMES
Combat Sports Anti-Doping (CSAD) says the French fighter’s adverse test at UFC Noche came from low-level ostarine contamination, not intentional use, and set her ineligibility from Oct. 19, 2026 through Jan. 19, 2027.
Combat Sports Anti-Doping (CSAD) announced that UFC fighter Manon Fiorot has accepted a three-month period of ineligibility after a violation of the UFC Anti-Doping Policy. CSAD said Fiorot tested positive for ostarine, a prohibited anabolic-agent substance, from an in-competition sample collected Sept. 12, 2026 at UFC Noche, where she fought Alexa Grasso.
CSAD reported that Fiorot provided a second sample on Oct. 19, 2026 before she was notified of the adverse finding. That later sample returned a negative result, which CSAD said aligned with her account that the supplements at issue were used only during fight week.
According to CSAD, Fiorot cooperated fully during the investigation and described working with a nutritionist ahead of UFC Noche. CSAD said the nutritionist provided several dietary supplements during fight week that were new to Fiorot, and she stopped using them after the event. CSAD added that two of the supplements, after portions were sent to the UFC ADP laboratory for analysis, tested positive for ostarine.
CSAD said the measured ostarine levels were extremely low and determined the findings were consistent with inadvertent exposure due to contamination rather than intentional use or pursuit of a performance advantage. CSAD also pointed out that neither supplement had been independently third-party tested and certified as banned-substance free.
CSAD said Fiorot’s ineligibility began on Oct. 19, 2026, the date she was notified of her provisional suspension, and will expire on Jan. 19, 2027. Because the event took place in Arizona, CSAD noted that the Arizona State Boxing and Mixed Martial Arts Commission will recognize and apply CSAD’s sanction without imposing a separate disciplinary penalty.
Comments
Community guidelines. Comments may be removed for violations.
Loading comments...